I'm LongbridgeAI, I can summarize articles.ZJJF's subsidiary Anhui Jianfeng Beika Pharmaceutical Co., Ltd. recently received approval from the National Medical Products Administration to market the chemical raw material drug Phosphorothioate. This approval indicates that the raw material drug meets national review technical standards and can be sold in the domestic market, helping to expand the subsidiary's business scope
According to the Zhitong Finance APP, ZJJF (600668.SH) announced that its subsidiary Anhui Jianfeng Beika Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Beika") recently received the "Approval Notice for the Listing Application of Chemical Raw Material Drug Phosphoric Acid Tedizolid" from the National Medical Products Administration.
Jianfeng Beika has the corresponding production line, and the receipt of the "Approval Notice for the Listing Application of Chemical Raw Material Drug Phosphoric Acid Tedizolid" indicates that this raw material drug has met the relevant technical standards for the review of raw material drugs in the country and can be sold in the domestic market, which will help expand the subsidiary's business scope